Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2329 to 2332 of 2332 entries
Sorted by: Best Match Show Resources per page
Soft palatal mass containing heterotopic neural tissue causing airway obstruction in a Pierre-Robin sequence patient.

Journal of surgical case reports

Allen DZ, Liu LX, Turner K, Greives MR, Nguyen PD, Roy S.
PMID: 34992764
J Surg Case Rep. 2021 Dec 31;2021(12):rjab510. doi: 10.1093/jscr/rjab510. eCollection 2021 Dec.

Pierre-Robin sequence (PRS) patients frequently exhibit symptoms of airway obstruction due to multiple etiologies, predominantly from glossoptosis and tongue base obstruction. Rarely, these patients can have palatal mass and even rarer is one of neural origin. To date, there...

Cite
Allen DZ, Liu LX, Turner K, et al. Soft palatal mass containing heterotopic neural tissue causing airway obstruction in a Pierre-Robin sequence patient. J Surg Case Rep. 2021;2021(12):rjab510doi: 10.1093/jscr/rjab510.
Allen, D. Z., Liu, L. X., Turner, K., Greives, M. R., Nguyen, P. D., & Roy, S. (2021). Soft palatal mass containing heterotopic neural tissue causing airway obstruction in a Pierre-Robin sequence patient. Journal of surgical case reports, 2021(12), rjab510. https://doi.org/10.1093/jscr/rjab510
Allen, David Z, et al. "Soft palatal mass containing heterotopic neural tissue causing airway obstruction in a Pierre-Robin sequence patient." Journal of surgical case reports vol. 2021,12 (2021): rjab510. doi: https://doi.org/10.1093/jscr/rjab510
Allen DZ, Liu LX, Turner K, Greives MR, Nguyen PD, Roy S. Soft palatal mass containing heterotopic neural tissue causing airway obstruction in a Pierre-Robin sequence patient. J Surg Case Rep. 2021 Dec 31;2021(12):rjab510. doi: 10.1093/jscr/rjab510. eCollection 2021 Dec. PMID: 34992764; PMCID: PMC8718372.
Copy Download .nbib Format: NLM
Introducing GRADE across the NICE clinical guideline program.

Journal of clinical epidemiology

Thornton J, Alderson P, Tan T, Turner C, Latchem S, Shaw E, Ruiz F, Reken S, Mugglestone MA, Hill J, Neilson J, Westby M, Francis K, Whittington C, Siddiqui F, Sharma T, Kelly V, Ayiku L, Chamberlain K.
PMID: 22406196
J Clin Epidemiol. 2013 Feb;66(2):124-31. doi: 10.1016/j.jclinepi.2011.12.007. Epub 2012 Mar 08.

OBJECTIVES: Grading of Recommendations Assessment, Development and Evaluation (GRADE) is a system for rating the confidence in estimates of effect and grading guideline recommendations. It promotes evaluation of the quality of the evidence for each outcome and an assessment...

Cite
Thornton J, Alderson P, Tan T, et al. Introducing GRADE across the NICE clinical guideline program. J Clin Epidemiol. 2012;66(2):124-31doi: 10.1016/j.jclinepi.2011.12.007.
Thornton, J., Alderson, P., Tan, T., Turner, C., Latchem, S., Shaw, E., Ruiz, F., Reken, S., Mugglestone, M. A., Hill, J., Neilson, J., Westby, M., Francis, K., Whittington, C., Siddiqui, F., Sharma, T., Kelly, V., Ayiku, L., & Chamberlain, K. (2013). Introducing GRADE across the NICE clinical guideline program. Journal of clinical epidemiology, 66(2), 124-31. https://doi.org/10.1016/j.jclinepi.2011.12.007
Thornton, Judith, et al. "Introducing GRADE across the NICE clinical guideline program." Journal of clinical epidemiology vol. 66,2 (2013): 124-31. doi: https://doi.org/10.1016/j.jclinepi.2011.12.007
Thornton J, Alderson P, Tan T, Turner C, Latchem S, Shaw E, Ruiz F, Reken S, Mugglestone MA, Hill J, Neilson J, Westby M, Francis K, Whittington C, Siddiqui F, Sharma T, Kelly V, Ayiku L, Chamberlain K. Introducing GRADE across the NICE clinical guideline program. J Clin Epidemiol. 2013 Feb;66(2):124-31. doi: 10.1016/j.jclinepi.2011.12.007. Epub 2012 Mar 08. PMID: 22406196.
Copy Download .nbib Format: NLM
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study.

Multiple sclerosis and related disorders

Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S.
PMID: 34871856
Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22.

BACKGROUND: In multiple sclerosis (MS) neurofilament light chain (NfL) is a marker of neuronal damage secondary to inflammation and neurodegeneration. NfL levels drop after commencement of disease-modifying treatment, especially the highly active ones. However, the factors that influence this...

Cite
Smets I, Holden D, Bianchi L, et al. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021;57:103409doi: 10.1016/j.msard.2021.103409.
Smets, I., Holden, D., Bianchi, L., Ammoscato, F., Allen-Philbey, K., Baker, D., Turner, B., Marta, M., Giovannoni, G., Macdougall, A., Schmierer, K., Hobart, J., & Gnanapavan, S. (2021). Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Multiple sclerosis and related disorders, 57103409. https://doi.org/10.1016/j.msard.2021.103409
Smets, Ide, et al. "Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study." Multiple sclerosis and related disorders vol. 57 (2021): 103409. doi: https://doi.org/10.1016/j.msard.2021.103409
Smets I, Holden D, Bianchi L, Ammoscato F, Allen-Philbey K, Baker D, Turner B, Marta M, Giovannoni G, Macdougall A, Schmierer K, Hobart J, Gnanapavan S. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study. Mult Scler Relat Disord. 2021 Nov 22;57:103409. doi: 10.1016/j.msard.2021.103409. Epub 2021 Nov 22. PMID: 34871856.
Copy Download .nbib Format: NLM
The Use and Significance of a Research Networking System.

Kahlon M, Yuan L, Daigre J, Meeks E, Nelson K, Piontkowski C, Reuter K, Sak R, Turner B, Weber GM, Chatterjee A.
UIID-AD: 1333
2014;16. doi: 10.2196/jmir.3137.

Background: Universities have begun deploying public Internet systems that allow for easy search of their experts, expertise, and intellectual networks. Deployed first in biomedical schools but now being implemented more broadly, the initial motivator of these research networking systems...

Cite
Kahlon M, Yuan L, Daigre J, et al. The Use and Significance of a Research Networking System. 2014;16doi: 10.2196/jmir.3137.
Kahlon, M., Yuan, L., Daigre, J., Meeks, E., Nelson, K., Piontkowski, C., Reuter, K., Sak, R., Turner, B., Weber, G. M., & Chatterjee, A. (2014). The Use and Significance of a Research Networking System. 16. https://doi.org/10.2196/jmir.3137
Kahlon, M, et al. "The Use and Significance of a Research Networking System." vol. 16 (2014). doi: https://doi.org/10.2196/jmir.3137
Kahlon M, Yuan L, Daigre J, Meeks E, Nelson K, Piontkowski C, Reuter K, Sak R, Turner B, Weber GM, Chatterjee A. The Use and Significance of a Research Networking System. 2014;16. doi: 10.2196/jmir.3137. UIID-AD: 1333.
Copy Download .nbib Format: NLM
Showing 2329 to 2332 of 2332 entries